Big surprise: Payers don't trust pharma. The fix? Risky trials and transparency
08.05.2014 / Fierce Pharma
Just in case you need more evidence that U.S. payers and pharma companies are at loggerheads, check out Ernst & Young's latest report on the pharma industry. It shows that drugmakers have certain opinions about their products and prices–and the people who write the checks have an entirely different set.